Universe Pharmaceuticals (UPC) Liabilities and Shareholders Equity: 2020-2024
- Universe Pharmaceuticals' Liabilities and Shareholders Equity rose 62.86% to $68.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was $229.5 million, marking a year-over-year decrease of 5.56%. This contributed to the annual value of $68.0 million for FY2024, which is 62.86% up from last year.
- Per Universe Pharmaceuticals' latest filing, its Liabilities and Shareholders Equity stood at $68.0 million for Q3 2024, which was up 37.47% from $49.4 million recorded in Q1 2024.
- Over the past 5 years, Universe Pharmaceuticals' Liabilities and Shareholders Equity peaked at $71.4 million during Q1 2022, and registered a low of $28.8 million during Q3 2020.
- Its 3-year average for Liabilities and Shareholders Equity is $60.1 million, with a median of $63.7 million in 2022.
- As far as peak fluctuations go, Universe Pharmaceuticals' Liabilities and Shareholders Equity soared by 143.52% in 2021, and later fell by 29.92% in 2023.
- Universe Pharmaceuticals' Liabilities and Shareholders Equity (Quarterly) stood at $28.8 million in 2020, then skyrocketed by 143.52% to $70.1 million in 2021, then dropped by 15.12% to $59.5 million in 2022, then fell by 29.92% to $41.7 million in 2023, then surged by 62.86% to $68.0 million in 2024.
- Its Liabilities and Shareholders Equity stands at $68.0 million for Q3 2024, versus $49.4 million for Q1 2024 and $41.7 million for Q3 2023.
